HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$0.98
Day range
$0.95 - $1.00
Year range
$0.71 - $1.96
Market cap
166.71M USD
Avg Volume
1.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 29.53M | 13.29% |
Operating expense | 28.45M | 2.60% |
Net income | -8.25M | 39.07% |
Net profit margin | -27.92 | 46.22% |
Earnings per share | -0.05 | 37.50% |
EBITDA | -6.57M | 46.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 49.55M | -15.53% |
Total assets | 126.52M | 2.35% |
Total liabilities | 158.19M | 6.98% |
Total equity | -31.67M | — |
Shares outstanding | 175.41M | — |
Price to book | -5.46 | — |
Return on assets | -14.29% | — |
Return on capital | -23.97% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.25M | 39.07% |
Cash from operations | -5.01M | -23.05% |
Cash from investing | 313.00K | -59.72% |
Cash from financing | -2.51M | -113.14% |
Net change in cash | -7.21M | -145.57% |
Free cash flow | 14.27M | 148.19% |
About
Founded
1996
Headquarters
Website
Employees
147